Form 4: NeuroPace Director Joseph Lacob Boosts Stake

NeuroPace Director Joseph Lacob acquired 1,131 shares of common stock at $9.94 per share as part of his compensation, increasing his beneficial ownership.

Summary

• Joseph Lacob, a Director of NeuroPace Inc. (NPCE), acquired 1,131 shares of common stock.
• The transaction occurred on September 19, 2025, at a price of $9.94 per share.
• These shares were issued pursuant to the company's non-employee director compensation policy, in lieu of quarterly retainer fees.
• Following this transaction, Mr. Lacob directly beneficially owns 13,211 shares.
• Additionally, he indirectly beneficially owns 128,174 shares through Lacob Ventures LLC and 223,554 shares through LCT18 Investments.
• The transaction was made pursuant to a Rule 10b5-1 plan.

Sentiment

Score: 7

Explanation: The acquisition of shares by a director, even as part of compensation, generally indicates a positive alignment of interests and confidence in the company's future. It's not an open market purchase, which would typically signal stronger conviction, but still a net positive.

Positives

• Director Joseph Lacob increased his direct beneficial ownership in NeuroPace Inc. by acquiring 1,131 shares.
• The acquisition of shares as part of director compensation aligns management interests with shareholder interests.

Industry Context

Insider transactions, particularly acquisitions by directors, are routinely monitored by investors as they can signal management's confidence in the company's future prospects. Stock-based compensation for non-employee directors is a common practice across industries to align their interests with shareholders.

Comparison to Industry Standards

• The practice of compensating non-employee directors with equity, as seen with the issuance of shares in lieu of retainer fees, is a widely adopted corporate governance standard across various industries, including the medical technology sector where NeuroPace operates. This method is generally viewed favorably as it directly links director incentives to the company's stock performance, aligning their financial interests with those of long-term shareholders.

Corporate Governance

Related Party Transactions

• Shares are held indirectly by Lacob Ventures LLC, an entity potentially controlled by the reporting person.
• Shares are held indirectly by LCT18 Investments, an entity potentially controlled by the reporting person.

Stakeholder Impact

• Shareholders: Increased alignment of director's interests with shareholder value through equity compensation.
• Management: Standard compensation practice for non-employee directors.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of shares by a non-employee director as part of their compensation package. While insider buying can be a positive signal, this is not an open market purchase driven by a discretionary investment decision. Therefore, it does not provide a strong enough catalyst to change an existing investment thesis, warranting a 'hold' recommendation for current investors.

Keywords

NeuroPace, NPCE, insider transaction, Form 4, director compensation, stock acquisition, Joseph Lacob, beneficial ownership, Rule 10b5-1